Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reboredo

Showing results (371-380 of 438) with videos related to

Pageof 44
Sort By:
Comprehensive Reviews in Food Science and Food Safety|December 18, 2020
Evaluation of the status quo of polyphenols analysis: Part II-Analysis methods and food processing effectsAna Sanches Silva, Patricia Reboredo-Rodríguez, Dalia I Sanchez-Machado, et al.
BMC Nephrology|August 15, 2023
Design and methodology of the SARCopenia trajectories and associations with adverse clinical outcomes in patients on HemoDialysis: the SARC-HD studyMarvery P Duarte, Marina S Pereira, Victor M Baião, et al.
Scientific Reports|March 11, 2017
Three electron beams from a laser-plasma wakefield accelerator and the energy apportioning questionX Yang, E Brunetti, D Reboredo Gil, et al.
Plants (Basel, Switzerland)|February 10, 2024
Nutritive Value and Bioactivities of a Halophyte Edible Plant: <i>Crithmum maritimum</i> L. (Sea Fennel)Iris Correia, Madalena Antunes, Carla Tecelão, et al.
Cancer Medicine|January 29, 2019
Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markersAna Fernández Montes, Nieves Martínez Lago, Marta Covela Rúa, et al.
BMC Cancer|June 5, 2019
First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)A Carrato, M Benavides, B Massutí, et al.
Plos One|November 24, 2012
Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab: a TTD group cooperative studyEduardo Díaz-Rubio, Auxiliadora Gómez-España, Bartomeu Massutí, et al.
Journal of Geriatric Oncology|June 26, 2020
First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL studyJosé Carlos Méndez Méndez, Mercedes Salgado Fernández, Juan de la Cámara Gómez, et al.
Artificial Organs|June 2, 2017
Factors Associated With Functional Capacity in Hemodialysis PatientsRodrigo Schinniger Assun Garcia, Leda Marília Fonseca Lucinda, Fábio Amaral Ramos, et al.
BMC Cancer|February 15, 2026
Comparative prognostic performance of the REBECCA score and the Tabernero classification in refractory metastatic colorectal cancer treated with regorafenib: a multicenter real-world studyNieves Martínez-Lago, Beatriz Carnero López, Juan Cruz de la Cámara Gómez, et al.
Pageof 44

Showing results (371-380 of 438) with videos related to

Sort By:
Pageof 44
Comprehensive Reviews in Food Science and Food Safety|December 18, 2020
Evaluation of the status quo of polyphenols analysis: Part II-Analysis methods and food processing effectsAna Sanches Silva, Patricia Reboredo-Rodríguez, Dalia I Sanchez-Machado, et al.
BMC Nephrology|August 15, 2023
Design and methodology of the SARCopenia trajectories and associations with adverse clinical outcomes in patients on HemoDialysis: the SARC-HD studyMarvery P Duarte, Marina S Pereira, Victor M Baião, et al.
Scientific Reports|March 11, 2017
Three electron beams from a laser-plasma wakefield accelerator and the energy apportioning questionX Yang, E Brunetti, D Reboredo Gil, et al.
Plants (Basel, Switzerland)|February 10, 2024
Nutritive Value and Bioactivities of a Halophyte Edible Plant: <i>Crithmum maritimum</i> L. (Sea Fennel)Iris Correia, Madalena Antunes, Carla Tecelão, et al.
Cancer Medicine|January 29, 2019
Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markersAna Fernández Montes, Nieves Martínez Lago, Marta Covela Rúa, et al.
BMC Cancer|June 5, 2019
First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)A Carrato, M Benavides, B Massutí, et al.
Plos One|November 24, 2012
Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab: a TTD group cooperative studyEduardo Díaz-Rubio, Auxiliadora Gómez-España, Bartomeu Massutí, et al.
Journal of Geriatric Oncology|June 26, 2020
First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL studyJosé Carlos Méndez Méndez, Mercedes Salgado Fernández, Juan de la Cámara Gómez, et al.
Artificial Organs|June 2, 2017
Factors Associated With Functional Capacity in Hemodialysis PatientsRodrigo Schinniger Assun Garcia, Leda Marília Fonseca Lucinda, Fábio Amaral Ramos, et al.
BMC Cancer|February 15, 2026
Comparative prognostic performance of the REBECCA score and the Tabernero classification in refractory metastatic colorectal cancer treated with regorafenib: a multicenter real-world studyNieves Martínez-Lago, Beatriz Carnero López, Juan Cruz de la Cámara Gómez, et al.
Pageof 44